Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Digestive Neuroendocrine Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Not applicableEnded earlyNCT00897312
What this trial is testing

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Who this might be right for
Melanoma
Vanderbilt-Ingram Cancer Center 7
Not applicableStudy completedNCT02264665
What this trial is testing

OPALINE : A Study Of Morbidity And Mortality At 2 Years

Who this might be right for
Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive
Pfizer 144
Not applicableEnrolling By InvitationNCT05600933
What this trial is testing

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

Who this might be right for
Solid TumorsHematologic MalignancyGastrointestinal Cancer+5 more
National Cancer Institute (NCI) 1,200
Testing effectiveness (Phase 2)Study completedNCT02807844
What this trial is testing

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerPancreatic CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 141
Testing effectiveness (Phase 2)Study completedNCT00861107
What this trial is testing

In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation

Who this might be right for
Metastatic Cancer
Mirror Biologics, Inc. 50
Early research (Phase 1)Study completedNCT02096614
What this trial is testing

Investigator Initiated Phase 1 Study of TBI-1201

Who this might be right for
Solid Tumors
Mie University 18
Large-scale testing (Phase 3)Looking for participantsNCT05477576
What this trial is testing

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Who this might be right for
GEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor Disease+4 more
RayzeBio, Inc. 338
Not applicableLooking for participantsNCT06592989
What this trial is testing

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

Who this might be right for
Pancreatic Neuroendocrine NeoplasmSorafenibGefitinib
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 20
Not applicableStudy completedNCT02043184
What this trial is testing

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

Who this might be right for
Prostatic NeoplasmsBreast NeoplasmsColorectal Neoplasms+2 more
Michigan State University 322
Large-scale testing (Phase 3)Study completedNCT04157985
What this trial is testing

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNSCLCBladder Cancer+10 more
Dan Zandberg 161
Testing effectiveness (Phase 2)Study completedNCT02327078
What this trial is testing

The Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

Who this might be right for
B-cell MalignanciesColorectal Cancer (CRC)Head and Neck Cancer+5 more
Incyte Corporation 307
Testing effectiveness (Phase 2)Looking for participantsNCT06472388
What this trial is testing

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsProgressionNeuroendocrine Tumor Grade 1+4 more
AC Camargo Cancer Center 100
Not applicableStudy completedNCT06143605
What this trial is testing

Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors

Who this might be right for
Rectal NeoplasmsNeuroendocrine Tumors
Yanhong Deng 527
Early research (Phase 1)UnknownNCT00986661
What this trial is testing

Assess PV-10 Chemoablation of Cancer of the Liver

Who this might be right for
Cancer Metastatic to the LiverHepatocellular CarcinomaMetastatic Melanoma+7 more
Provectus Biopharmaceuticals, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT05259696
What this trial is testing

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Who this might be right for
OncologyMelanomaOvarian Cancer+14 more
Palleon Pharmaceuticals, Inc. 69
Not applicableUnknownNCT05554744
What this trial is testing

EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors

Who this might be right for
Multiple Endocrine Neoplasia Type 1Pancreatic Neuroendocrine Tumor
Guangxi Medical University 20
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Not applicableEnrolling By InvitationNCT00068003
What this trial is testing

Harvesting Cells for Experimental Cancer Treatments

Who this might be right for
MelanomaGastrointestinal CancerMetastatic Cancer+2 more
National Cancer Institute (NCI) 7,000
Next Page